ENOUGH OF THE ENDLESS SEARCH

NUCALA is a prescription medicine for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA). NUCALA was approved for EGPA in December 2017 and is the only biologic for EGPA with 6+ years of patient experience.

Let’s get to it with NUCALA. Think:

LONGER time in remission*

FEWER relapses per year

LOWER oral steroid dose

Results may vary.

  • *“Remission” was defined as no active vasculitis and a prednisone or prednisolone dose less than or equal to 4 mg per day.
  • “Relapse” was defined as worsening symptoms that required increased steroid dose, and/or increase in dose or start of immunosuppressants, and/or hospitalization.

Once a month. At home. On YOUR time.

When it comes to your treatment, convenience is key. The NUCALA Autoinjector can be taken at home–just once a month. Want to learn more about using the Autoinjector? 

  • Every 4 weeks.
Get Real: NUCALA patient Ben

Ben lives his life with NUCALA

Ben found out he had EGPA during his sophomore year of college. After worsening symptoms, hospitalizations, and many steroids, Ben’s life changed when NUCALA became the first FDA-approved treatment for EGPA. Now Ben lives life on his terms, with NUCALA.

Get to it

Looking for support? We've got your back.

MyNUCALA offers many resources, like:

  • Answers to your questions about NUCALA   
  • Guidance and tools to help you work with your specialty pharmacy
  • Refill text reminders 

Talk to your doctor to see if adding NUCALA is right for you.

Approved Use & Safety Info

Approved Use

Important Safety Information

Approved Use

NUCALA is a prescription medicine for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA).

Important Safety Information

Do not use NUCALA if you are allergic to mepolizumab or any of the ingredients in NUCALA.

NUCALA can cause serious side effects, including:

  • allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen after you get your NUCALA injection. Allergic reactions can sometimes happen hours or days after you get a dose of NUCALA. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • swelling of your face, mouth, and tongue
    • breathing problems
    • fainting, dizziness, feeling lightheaded (low blood pressure)
    • rash
    • hives
  • herpes zoster infections that can cause shingles have happened in people who received NUCALA.

Before receiving NUCALA, tell your healthcare provider about all of your medical conditions, including if you:

  • are taking oral or inhaled corticosteroid medicines. Do not stop taking your other medicines, including your corticosteroid medicines, unless instructed by your healthcare provider because this may cause other symptoms to come back.
  • have a parasitic (helminth) infection.
  • are pregnant or plan to become pregnant. It is not known if NUCALA may harm your unborn baby.
  • are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will use NUCALA and breastfeed. You should not do both without talking with your healthcare provider first.
  • are taking prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and tiredness (fatigue).

Please see full Prescribing Information for NUCALA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report negative side effects to GSK at gsk.public.reportum.com or 1-888-825-5249.
Visit GSK Help Center website

Explore the GSK Help Center website to find customer service support and contact information.

Visit GSK For You website

If you have questions about how to access your GSK medication or need cost information, visit gskforyou.com or call 1-866-GSK-FOR-U (1-866-475-3678).